RxDx assay as a companion diagnostic to identify c-Met protein expression in non-squamous NSCLC patients eligible for treatment with Emrelis.

Brekiya consists of dihydroergotamine mesylate, an ergotamine derivative, in a single-dose autoinjector for subcutaneous administration.

The Food and Drug Administration (FDA) has approved Optison ™ (perflutren protein-type A microsphere) injectable suspension for use in pediatric patients with suboptimal echocardiograms to opacify the ...

Fresh & Ready Foods has voluntarily recalled products with “use by” dates from April 22 to May 19, 2025, CNN said. The items were sold under the brand names Fresh & Ready Foods, City Point Market ...

The Teal Wand is an at-home vaginal self-collection device intended to test for 14 types of high-risk HPV that have the ...

The 3 new color additives are Galdieria extract blue, butterfly pea flower extract, and calcium phosphate. HealthDay News — The US Food and Drug Administration announced the approval of 3 new color ...

Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.

Increased risk for attacks seen in women younger than 35 years, those with eosinophilia, those with lower corticosteroid use.

Friede's passion nearly cost him his life in 2001, when he let 2 cobras bite him and ended up in a coma for four days.

The investigational transdermal delivery system, known as Xulane Lo, is designed to deliver 150mcg of norelgestromin and 17.5mcg of ethinyl estradiol per day.

Topline data were announced from two phase 3 studies evaluating MR-107A-02 for the treatment of moderate to severe acute pain.